Italy· 023402023
SEREPRILE*10 fiale IM EV 100 mg 2 ml
A tiapride product containing tiapride, registered in Italy by NEURAXPHARM ITALY SpA, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Tiapride is registered in 7 of 19 countries.
Countries holding a registration under ATC N05AL03 (tiapride), each read from that country’s own register.
- This record: Italy
- 6 of them publish a price we can compare per daily dose
Tiapride · ATC N05AL03
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Germany
- Italyprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of tiapride costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tiapride · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.18
The record
At a glance
- Active substance
- Tiapride
- Manufacturer
- NEURAXPHARM ITALY SpA
- Country
- Italy (IT)
- ATC code
- N05AL03
- ATC class
- Tiapride
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic023402023SEREPRILE*10 fiale IM EV 100 mg 2 mlEUR 4.13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for tiapride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tiapride · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Tiapride in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTIAPRAZentiva, k.s., Praha
- PolandTiaprid PMCSMedezin Sp. z o.o.
- GermanyTiaprid -BiomoAet, De
- Japanチアプリド塩酸塩日医工
- FranceTIAPRIDAL 100 mg, comprimé sécableNEURAXPHARM FRANCE
- SpainTIAPRIZAL 100 mg COMPRIMIDOSNeuraxpharm Spain S.L.U.
- BelgiumTiapridal 100 mgNeuraxpharm Belgium
- SwitzerlandTiapridal, TablettenNeuraxpharm Switzerland AG
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Delpral, Tiaprid G.L.
- Belgium · Tiapridal
- Bulgaria · Тиаприд G.L.
- Czechia · Tiapra, Tiapralan
- Germany · Tiaprid 1 A Pharma, Tiaprid 1a Pharma
- Spain · Tiaprizal
- France · Tiapridal, Tiapride Sandoz
- Hungary · Tiager, Tiapridal
- Lithuania · Hipokin, Tiapridal
- Luxembourg · Tiapridal
- Poland · Tiaprid Pmcs, Tiapridal
- Portugal · Tiaprida Generis, Tiapridal
- Romania · Tiapridal
- Slovakia · Tiaprid Fmk, Tiaprid Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea6810b4-960f-47cc-87d1-0c53122a6678 GET /v1/drugs/ea6810b4-960f-47cc-87d1-0c53122a6678?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4.13,
"source": "aifa",
"currency": "EUR",
"strength": "TIAPRIDE 100MG 10 UNITA' USO PARENTERALE",
"substance": "Tiapride",
"equivalence_group": "SOA",
"transparency_flag": null
}See everything about tiapride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.